New application of traditional Chinese medicine compound medicinal composition
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A use and drug technology, applied in the field of traditional Chinese medicine compound pharmaceutical compositions, can solve the problems of inability to recognize and express trophoblast cells, and the fetal placenta does not have lethality, etc., achieves good clinical application prospects, improves maternal-fetal immune tolerance, and improves maternal-fetal immunity. effect of tolerance
Active Publication Date: 2017-11-07
CHENGDU UNIV OF TRADITIONAL CHINESE MEDICINE
View PDF3 Cites 3 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0004] HLA-G, human leucocyte antigen-G (human leucocyte antigen-G), has a similar domain function to MHC-I, but it has a high degree of isotype characteristics in different species, so maternal NK cells cannot recognize and express this Antigen trophoblast, so it is not lethal to fetal placenta
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0023] The preparation of embodiment 1 pharmaceutical composition of the present invention
[0025] Preparation method: the above six flavors, except for the antler gum, the other five flavors such as Rehmannia glutinosa are crushed into fine powder, sieved and mixed. Take antler gum, mix it with the above fine powder, dry and seal it for storage, make powder powder, and take it with water; or add 10g of refined honey and an appropriate amount of water for every 100g of powder, make pills, dry, and get pills; or take powder , adding pharmaceutically acceptable excipients or auxiliary ingredients to prepare granules, tablets, capsules, and oral liquids.
Embodiment 2
[0026] The preparation of embodiment 2 pharmaceutical compositions of the present invention
[0028] Prepared according to the method of Example 1.
Embodiment 3
[0029] The preparation of embodiment 3 pharmaceutical composition of the present invention
[0030] Weigh raw materials: Rehmannia glutinosa 18g, dogwood 9g, yam 8g, medlar 9g, dodder 8g, antler glue 8g; prepared according to the method in Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses application of a composition to preparation of drugs for improving the maternal-fetal immunologic tolerance. The composition comprises the following raw materials in parts by weight: 18-30 parts of prepared rehmannia root, 9-12 parts of dogwood, 8-16 parts of yams, 9-12 parts of medlar, 8-16 parts of semen cuscutae and 8-16 parts of deerhorn glue. The kidney-tonifying composition can improve the maternal-fetal immunologic tolerance, is expectedly used for treating pathological pregnancy such as habitual abortion, pregnancy induced hypertension and IUGR (intrauterine growth retardation) caused by maternal-fetal immunologic imbalance, and has a good clinical application prospect.
Description
technical field [0001] The invention relates to a new application of a traditional Chinese medicine compound pharmaceutical composition, in particular, an application in preparing a medicine for improving maternal-fetal immune tolerance. Background technique [0002] Pregnancy is a complex physiological process. From the perspective of immunology, the fetus and its appendages with paternal antigens are similar to semi-allogeneic transplants, which will cause the immune system of the mother to recognize and respond to them; Immune tolerance, that is, maternal-fetal immune tolerance, so that the fetus will not be rejected. Maternal-fetal immune tolerance is very important for a successful pregnancy. Once the maternal-fetal immune system is out of balance, pathological pregnancies such as habitual abortion, pregnancy-induced hypertension, and IUGR will occur. [0003] Traditionally, it is generally believed that any cell membrane has MHC-I as its surface marker, and MHC-I ref...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more